[Oral cavity as a target and a marker of environmental exposures: diseases diagnosed during adulthood].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Transliterated Title:
      La sphère orale, cible et marqueur de l’exposition environnementale - II. Maladies diagnostiquées chez l’adulte.
    • Source:
      Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1958-5381 (Electronic) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
    • Publication Information:
      Publication: <2003->: Paris : EDK
      Original Publication: [Paris] : Flammarion, [1985-
    • Subject Terms:
      Biomarkers/*analysis ; Drug-Related Side Effects and Adverse Reactions/*diagnosis ; Drug-Related Side Effects and Adverse Reactions/*epidemiology ; Environmental Exposure/*analysis ; Environmental Pollutants/*toxicity ; Mouth/*physiology; Administration, Oral ; Adult ; Age of Onset ; Chronic Disease ; Diet ; Drug-Related Side Effects and Adverse Reactions/etiology ; Environmental Pollutants/administration & dosage ; Food Contamination/analysis ; Humans ; Mouth/drug effects ; Mouth/pathology ; Pharmaceutical Preparations
    • Abstract:
      The oral cavity is one of the main route for environmental contaminations associated to many chronic diseases via alimentation, medications and respiration. Other factors may also impact the oral environment, some of them are endogenous, like microbiota, hormones and saliva, and others are exogenous, like dental materials and pathogens.
      (© 2020 médecine/sciences – Inserm.)
    • References:
      Marant-Micallef C, Shield KD, Vignat J, et al. Nombre et fractions de cancers attribuables au mode de vie et à l’environnement en France métropolitaine en 2015: résultats principaux. Bull Epidémiol Hebd 2018 ; 21 : 442–448.
      Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst 2011 ; 103 : 1827–1839.
      Mehanna H, Bryant TS, Babrah J, et al. Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK - a cross-sectional study. Clin Infect Dis 2019 ; 69 : 1296–1302.
      Lazcano-Ponce E, Salmerón J, González A, et al. Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study. Salud Publica Mex 2018 ; 60 : 703–712.
      Emmett S, Jenkins G, Boros S, et al. Low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in Queensland. Australia. ANZ J Surg 2017 ; 87 : 714–719.
      Kehm RD, Yang W, Tehranifar P, Terry MB. 40 Years of change in age - and stage-specific cancer incidence rates in US women and men. JNCI Cancer Spectr 2019; 3 : pkz038.
      Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003 ; 61 : 1115–1117.
      Wotton CJ, Green J, Brown A, et al. Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women. Bone 2019 ; 124 : 69–74.
      Watts NB, Grbic JT, Binkley N, et al. Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years. J Clin Endocrinol Metab 2019 ; 104 : 2443–2452.
      Eleutherakis-Papaiakovou E, Bamias A. Antiresorptive treatment-associated ONJ. Eur J Cancer Care 2017 ; 26 :.
      Adornato MC, Morcos I, Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 2007 ; 138 : 971–977.
      Pérez-Chaparro PJ, Gonçalves C, Figueiredo LC, et al. Newly identified pathogens associated with periodontitis: a systematic review. J Dent Res 2014 ; 93 : 846–858.
      Meuric V, Le Gall-David S, Boyer E, et al. Signature of microbial dysbiosis in periodontitis. Appl Environ Microbiol 2017 ; 83 : e00462–e00417.
      Pussinen PJ, Alfthan G, Jousilahti P, et al. Systemic exposure to Porphyromonas gingivalis predicts incident stroke. Atherosclerosis 2007 ; 193 : 222–228.
      Sen S, Chung M, Duda V, et al. Periodontal disease associated with aortic arch atheroma in patients with stroke or transient ischemic attack. J Stroke Cerebrovasc Dis 2017 ; 26 : 2137–2144.
      Delbosc S, Rouer M, Alsac JM, et al. High-density lipoprotein therapy inhibits Porphyromonas gingivalis-induced abdominal aortic aneurysm progression. Thromb Haemost 2016 ; 115 : 789–799.
      Peres MA, Macpherson LMD, Weyant RJ, et al. Oral diseases: a global public health challenge. Lancet 2019 ; 394 : 261–272.
      Alaluusua S.. Aetiology of molar-incisor hypomineralisation: a systematic review. Eur Arch Paediatr Dent 2010 ; 11 : 53–58.
      Jedeon K, Houari S, Loiodice S, et al. Chronic exposure to bisphenol A exacerbates dental fluorosis in growing rats. J Bone Miner Res 2016 ; 31 : 1955–1966.
      Silva MJ, Scurrah KJ, Craig JM, et al. Etiology of molar incisor hypomineralization: a systematic review. Community Dent Oral Epidemiol 2016 ; 44 : 342–353.
      Houari S, Picard E, Wurtz T, et al. Disrupted iron storage in dental fluorosis. J Dent Res 2019 ; 98 : 994–1001.
      Chardin H, Mercier K, Frydman C, Vollmer N. Surface plasmon resonance imaging: a method to measure the affinity of the antibodies in allergy diagnosis. J Immunol Methods 2014 ; 405 : 23–28.
      Porto-Mascarenhas EC, Assad DX, Chardin H, et al. Salivary biomarkers in the diagnosis of breast cancer: A review. Crit Rev Oncol Hematol 2017 ; 110 : 62–73.
      Guerra EN, Acevedo AC, Leite AF, et al. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: a systematic review and meta-analysis. Oral Oncol 2015 ; 51 : 805–818.
      Babajko S, Gayrard V, Houari S, et al. La sphère orale, cible et marqueur de l’exposition environnementale. I. Défauts du développement dentaire. Med Sci (Paris) 2020; 36 : 225–30.
    • Grant Information:
      AP-FSE-17-001 Fondation Santé Environnementale de la Mutuelle Familiale, Paris, France; Institut National de la Santé et de la Recherche Médicale; Université de Paris
    • Contributed Indexing:
      Local Abstract: [Publisher, French] La sphère orale, cible et marqueur de l’exposition environnementale - II. Maladies diagnostiquées chez l’adulte. [Publisher, French] La cavité buccale est l’une des voies majeures des contaminations environnementales connues pour être impliquées dans de nombreuses maladies chroniques via l’alimentation, les médications ou même la respiration. D’autres facteurs peuvent également influer sur l’environnement oral, certains endogènes, comme le microbiote, les variations hormonales, la salive, d’autres exogènes, comme les biomatériaux dentaires et les agents pathogènes. Cette synthèse fait le point sur l’état des connaissances, les questions et controverses sur les facteurs environnementaux courants au contact de la sphère orale impliqués dans les maladies de la cavité orale diagnostiquées chez l’adulte telles que les cancers des voies aéro-digestives supérieures, les ostéonécroses des mâchoires, et les parodontites, ces dernières pouvant d’ailleurs être directement liées à des pathologies systémiques comme les accidents vasculaires cérébraux, la maladie d’Alzheimer ou la maladie de Crohn notamment. La caractérisation des impacts environnementaux sur le microbiote oral, la salive, l’émail dentaire peut servir de marqueur pronostic précoce des maladies diagnostiquées ultérieurement, en lien avec ces expositions.
    • Accession Number:
      0 (Biomarkers)
      0 (Environmental Pollutants)
      0 (Pharmaceutical Preparations)
    • Publication Date:
      Date Created: 20200402 Date Completed: 20200930 Latest Revision: 20220413
    • Publication Date:
      20221213
    • Accession Number:
      10.1051/medsci/2020025
    • Accession Number:
      32228841